Stay updated on PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page.

Latest updates to the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe study record history now shows the latest revision as v3.6.5, replacing the previous latest revision v3.6.4. This reflects an administrative update to the versioning of the record rather than changes to study data or eligibility.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe study record history adds a new revision entry labeled v3.6.4, replacing the previous v3.6.3. This reflects a small update to the page record.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe record history now shows the latest revision as v3.6.3. This reflects a minor update to the study record's release notes in the revision history.SummaryDifference0.1%

- Check44 days agoChange DetectedA new page revision label v3.6.2 was added to the study record history, replacing the earlier v3.6.0 and signaling an update to the record.SummaryDifference0.1%

- Check58 days agoChange DetectedThe history now includes a note that recruitment is closed (no longer looking for participants), and the current revision is marked as v3.6.0, with the prior v3.5.5 revision removed.SummaryDifference0.5%

- Check65 days agoChange DetectedThe study record history now includes a new revision entry, Revision: v3.5.5, replacing Revision: v3.5.4. This change updates the page’s version history but does not modify trial details or user-facing content.SummaryDifference0.1%

Stay in the know with updates to PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page.